Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Deloitte
US Department of Justice
Medtronic
Covington
Farmers Insurance
Healthtrust
QuintilesIMS
Dow

Generated: May 20, 2018

DrugPatentWatch Database Preview

Tentative Approvals for: Mylan

« Back to Dashboard

Mylan Drugs with Tentative Approvals

Applicant Generic Name NDA Strength Dosage Form
Mylan quinapril hydrochloride 076036 EQ 40MG BASE TABLET;ORAL
Mylan Pharms Inc atomoxetine hydrochloride 079021 80MG CAPSULE; ORAL
Mylan Pharms Inc cinacalcet hydrochloride 203422 90MG TABLET;ORAL
Mylan Pharms Inc pregabalin 091228 50MG CAPSULE; ORAL
Applicant Generic Name NDA Strength Dosage Form

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
QuintilesIMS
US Department of Justice
Cipla
US Army
McKinsey
Federal Trade Commission
Boehringer Ingelheim
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.